BWM-32955-97425
2 vaccinations
7 coded responses
20 check-ins
7 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 726 / AR
- Registered
- 2021-01-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-19
Registered in v-safe
-
2021-01-19
Dose 1 — Pfizer-BioNTech
-
2021-01-23
Survey response — days 1–6 daily, dose 1MedDRA: Restlessness — Feeling: Good · Site: Pain · Headache · Be unable to do your normal daily activitiesFree text: RestlessnessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-02-03
-
2021-02-09
Dose 2 — Pfizer-BioNTech
- 2021-02-09
-
2021-02-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-11
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-12
Survey response — days 1–6 daily, dose 2MedDRA: Sneezing — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache · Be unable to do your normal daily activitiesFree text: SneezingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-14
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Good · Site: Pain, Redness, Swelling, Itching · NauseaFree text: DizzyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tiredness, NauseaAdult check-in
-
2021-02-16
Health check-in — day 7, dose 2Feeling: Good · Site: Redness, Itching · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-23
- 2021-03-02
- 2021-03-11
-
2021-03-16
Survey response — day 35, dose 2MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-23
-
2021-05-11
Survey response — 3 months, dose 2MedDRA: Palpitations — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Worsening heart palpitations (not anxiety related)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-11
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-08-10
Survey response — 6 months, dose 2MedDRA: Intermenstrual bleeding — Feeling: GoodFree text: Spotting between periodsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-02-09
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous, Menstruation irregular, Office visit, Palpitations — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Menstrual irregularities, miscarriages, heart palpitations · Healthcare visit (other): In person, ultrasoundsMedDRA releases: 2024-11 · check-in free text available
-
2022-02-09
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-02-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-19 | Pfizer-BioNTech | |
| 2 | 2021-02-09 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-11 | Unsuccessful | |
| 2022-02-09 | Unsuccessful |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Restlessness
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Sneezing
Systemic reaction (other): Dizzy
Release 5 — day 35, dose 2
Symptoms: Fatigue
Release 8 — 3 months, dose 2
Symptoms: Worsening heart palpitations (not anxiety related)
Release 9 — 6 months, dose 2
Symptoms: Spotting between periods
Release 11 — 12 months, dose 2
Symptoms: Menstrual irregularities, miscarriages, heart palpitations
Healthcare visit (other): In person, ultrasounds
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Intermenstrual bleeding | ✓ | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Palpitations | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Restlessness | ✓ | ✓ | ✓ |
| SRO | Sneezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release